Sleep@Home SRL

Sleep@Home reported total assets of 22,995 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Feb 2026).

Company number (CBE) 0758.809.323 · VAT BE0758809323
1030 Schaerbeek
active in Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
operating since 26 Nov 2020 (≈ 6 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Sleep@Home shows with a free account.

See the score
Profile
SRL since 2020
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−10,605 €
Equity5,097 €
Cash2,961 €
EBITDA2,423 €
Total assets22,995 €
The line marks its sector median: 32.2% (180 companies).

Change 2022 → 2025: Equity -25 % Total assets -61 %

Accounts of the company itself (not consolidated).

The full file covers 4 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Sleep@Home's annual accounts

2025202420232022
Net result−10,605 €
Equity5,097 €
Cash2,961 €
EBITDA2,423 €
Total assets22,995 €

Filed annual accounts

  • Year ended 30 Jun 2025filed on 26 Feb 2026
  • Year ended 30 Jun 2024filed on 28 Feb 2025
  • Year ended 30 Jun 2023filed on 29 Feb 2024
  • Year ended 30 Jun 2022filed on 16 Feb 2023

Sleep@Home's financial analysis

Management and control of Sleep@Home

3 active director(s) in the register.

Sleep@Home's shareholders and holdings →

Sleep@Home's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0758.809.323
VAT number
BE0758809323
Peppol
Registered · 0208:0758809323 · as of 10 Nov 2026
Legal form
SRL
Incorporated
26 Nov 2020
Registered office
1030 Schaerbeek
Latest accounts
2025 · filed on 26 Feb 2026
Activity
Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)

Sleep@Home (SRL) has been based in Schaerbeek since 2020, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net loss of 10,605 € and equity of 5,097 €; its revenue is not published. Its solvency stands at 22.2%, below the median of its sector (32.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Sleep@Home

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Sleep@Home

What is the revenue of Sleep@Home?

Sleep@Home files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Sleep@Home?

In Belgium, the VAT number is the company number prefixed with BE: BE0758809323 for Sleep@Home, if the company is VAT-registered. Its company number (CBE) is 0758.809.323.

Where is the registered office of Sleep@Home?

According to the CBE register, the registered office of Sleep@Home is in 1030 Schaerbeek.

What is the equity of Sleep@Home?

At the close of the 2025 financial year, the equity of Sleep@Home amounts to 5,097 €, a solvency of 22.2% of total assets.

Who manages Sleep@Home?

The register lists 3 active mandates at Sleep@Home. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Sleep@Home

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 13 Aug 2026

No credit card, no commitment.

What each plan unlocks →